Chances are that you know someone who lives with a chronic condition that requires ongoing, regular treatment. Often, that treatment includes injections. More than ever, patients and families are finding themselves being transitioned from office visits to self-administration of injections at home.
This article takes a look at the emerging drug delivery device landscape, and the opportunity for innovators to seek new ways of accommodating patient capabilities and deficits, while increasing the safety, comfort and reducing risks of the self-administration market.